The Delhi High Court Thursday directed Serum Institute of India and Bharat Biotech to disclose their capacities to manufacture Covaxin, Covishield vaccines. The high court also asked the Centre to explain in affidavit the rationale behind keeping strict control over class of persons who can be vaccinated against COVID-19 currently as under the present system those above the age of 60 years or between 45 to 60 years with comorbidities can receive vaccination. A bench of Justices Vipin Sanghi and Rekha Palli said the two institutes Serum Institute of India and Bharat Biotech have more capacity to provide the vaccines but it seems that they are not exploiting it fully.